# Nitrazepam
*Source: https://go.drugbank.com/drugs/DB01595*

## Overview

### Description

This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.

### Background

A benzodiazepine derivative used as an anticonvulsant and hypnotic.

### Indication

Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.

### Pharmacodynamics

Nitrazepam is a type of benzodiazepine drug. It is a powerful hypnotic drug which possesses strong sedative, anxiolytic, amnestic, anticonvulsant, and skeletal muscle relaxant properties. Nitrazepam shortens the time required to fall asleep and lengthens the duration of sleep. It is also useful for the management of myoclonic seizures.

### Mechanism of Action

GABA(A) Receptor
Positive allosteric modulator
GABA(A) Receptor Benzodiazepine Binding Site
Ligand

### Absorption

Bioavailability is 53-94% following oral administration.

### Half-life

15-38 hours (mean elimination half life 26 hours).

### Toxicity

An overdose of nitrazepam may lead to impaired breathing, dizziness, decreased cognition and balance, bluish nails and lips, slurred speech, and extreme somnolence, among others. In severe overdose, these symptoms may progress to a coma with a possibility of death.

### Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

1,2-Benzodiazepine
The risk or severity of CNS depression can be increased when Nitrazepam is combined with 1,2-Benzodiazepine.
Abametapir
The serum concentration of Nitrazepam can be increased when it is combined with Abametapir.
Acetaminophen
Nitrazepam may increase the hepatotoxic activities of Acetaminophen.
Acetazolamide
The risk or severity of CNS depression can be increased when Acetazolamide is combined with Nitrazepam.
Acetophenazine
The risk or severity of CNS depression can be increased when Acetophenazine is combined with Nitrazepam.

### Food Interactions

Avoid alcohol.
Limit caffeine intake.
Take with food.

## Chemical Information

**DrugBank ID:** DB01595

**Synonyms:** 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
2,3-dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one
7-nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
N-desmethylnimetazepam
Nitrazepam
Nitrazépam
Nitrazepamum

**Chemical Formula:** C
15
H
11
N
3
O
3

**SMILES:** [O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1

**Weight:** Average: 281.2661
Monoisotopic: 281.080041233

**IUPAC Name:** 7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one

## Additional Information

### Modality

Small Molecule

### Patents

0

### Indicated Conditions

2

### Phase 0

0

### Phase 1

0

### Phase 2

1

### Phase 3

2

### Phase 4

1

### Therapeutic Categories

Benzodiazepines and benzodiazepine
derivatives

### Summary

Nitrazepam
is a long-acting benzodiazepine with intermediate onset commonly used to treat panic disorders, severe anxiety, insomnia, and seizures.

### Brand Names

Mogadon

### Generic Name

Nitrazepam

### DrugBank Accession Number

DB01595

### Groups

Approved

### Structure

3D
Download
MOL
SDF
3D-SDF
PDB
SMILES
InChI
Similar Structures
Structure for Nitrazepam (DB01595)
×
Close

### External IDs

N05CD02
NSC-58775
RO 4-5360
RO 5-3059

### Associated Conditions

Indication Type
Indication
Combined Product Details
Approval Level
Age Group
Patient Characteristics
Dose Form
Management of
Insomnia
••••••••••••
Create Account
Management of
Myoclonic seizures
••••••••••••
Create Account
Create Account

### Mechanism of action

Nitrazepam belongs to a group of medicines called benzodiazepines. This drug affects central benzodiazepine receptors, which are associated with inhibitory GABA (gamma amino butyric acid)receptors, leading to enhanced GABA binding activity. GABA is a major neurotransmitter in the brain, which causes somnolence, relaxation of muscles, a decrease in anxiety and general central nervous system depression. Nitrazepam has anticonvulsant properties that may be attributed to its ability to bind to voltage-dependent sodium channels. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.
Target
Actions
Organism
A
GABA(A) Receptor
positive allosteric modulator
Humans
A
GABA(A) Receptor Benzodiazepine Binding Site
ligand
Humans
U
Gamma-aminobutyric acid receptor subunit alpha-1
antagonist
Humans
U
Sodium channel protein type 1 subunit alpha
other/unknown
Humans

### International/Other Brands

Alodorm
/
Apodorm
/
Arem
/
Atempol
/
Benzalin
/
Calsmin
/
Eatan
/
Eunoctin
/
Gerson
/
Hipnax
/
Hipsal
/
Ibrovek
/
Imeson
/
Imesont
/
Insoma
/
Nelbon
/
Nelmat
/
Neozepam
/
Neuchlonic
/
Nitrados
/
Nitrosun
/
Ormodon
/
Pacisyn
/
Paxadorm
/
Paxisyn
/
Pelson
/
Persopit
/
Radedorm
/
Relact
/
Remnos
/
Somitran
/
Somnite
/
Sonebon
/
Sonnolin
/
Surem
/
Trazenin
/
Unisomnia

### Brand Name Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Mogadon
Tablet
5 mg
Oral
Aa Pharma Inc
1980-12-31
Not applicable
Canada
Mogadon
Tablet
10 mg
Oral
Aa Pharma Inc
1980-12-31
Not applicable
Canada
Nitrazadon
Tablet
10 mg
Oral
Aa Pharma Inc
1996-11-08
2014-06-25
Canada
Nitrazadon
Tablet
5 mg
Oral
Aa Pharma Inc
1996-11-08
2014-06-25
Canada
Nitrazepam-10
Tablet
10 mg
Oral
Pro Doc Limitee
2004-07-29
2010-07-13
Canada

### Generic Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Apo-nitrazepam
Tablet
5 mg
Oral
Apotex Corporation
2002-09-17
Not applicable
Canada
Apo-nitrazepam
Tablet
10 mg
Oral
Apotex Corporation
2002-09-17
Not applicable
Canada
Sandoz Nitrazepam
Tablet
10 mg
Oral
Sandoz S.P.A.
1997-12-02
2018-08-01
Canada
Sandoz Nitrazepam
Tablet
5 mg
Oral
Sandoz S.P.A.
1997-12-02
2018-08-01
Canada

### ATC Codes

N05CD02 — Nitrazepam
N05CD — Benzodiazepine derivatives
N05C — HYPNOTICS AND SEDATIVES
N05 — PSYCHOLEPTICS
N — NERVOUS SYSTEM

### Drug Categories

Anti-Anxiety Agents
Anticonvulsants
Benzazepines
Benzodiazepine hypnotics and sedatives
Benzodiazepines and benzodiazepine derivatives
Benzodiazepinones
Central Nervous System Agents
Central Nervous System Depressants
Cytochrome P-450 CYP2E1 Inhibitors
Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Substrates
GABA Agents
GABA Modulators
Heterocyclic Compounds, Fused-Ring
Hypnotics and Sedatives
Muscle Relaxants
Muscle Relaxants, Centrally Acting Agents
Nervous System
Neurotransmitter Agents
Psycholeptics
Psychotropic Drugs
Tranquilizing Agents

### Chemical TaxonomyProvided byClassyfire

Description
This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Benzodiazepines
Sub Class
1,4-benzodiazepines
Direct Parent
1,4-benzodiazepines
Alternative Parents
Alpha amino acids and derivatives
/
Nitroaromatic compounds
/
Benzene and substituted derivatives
/
Secondary carboxylic acid amides
/
Lactams
/
Ketimines
/
Propargyl-type 1,3-dipolar organic compounds
/
Organic oxoazanium compounds
/
Azacyclic compounds
/
Organopnictogen compounds
/
Organic zwitterions
/
Organic oxides
/
Hydrocarbon derivatives
/
Carbonyl compounds
show 4 more
Substituents
1,4-benzodiazepine
/
Allyl-type 1,3-dipolar organic compound
/
Alpha-amino acid or derivatives
/
Aromatic heteropolycyclic compound
/
Azacycle
/
Benzenoid
/
C-nitro compound
/
Carbonyl group
/
Carboxamide group
/
Carboxylic acid derivative
/
Hydrocarbon derivative
/
Imine
/
Ketimine
/
Lactam
/
Monocyclic benzene moiety
/
Nitroaromatic compound
/
Organic 1,3-dipolar compound
/
Organic nitro compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxoazanium
/
Organic oxygen compound
/
Organic zwitterion
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Propargyl-type 1,3-dipolar organic compound
/
Secondary carboxylic acid amide
show 18 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
C-nitro compound, 1,4-benzodiazepinone (
CHEBI:7581
)

### Kingdom

Organic compounds

### Super Class

Organoheterocyclic compounds

### Class

Benzodiazepines

### Sub Class

1,4-benzodiazepines

### Direct Parent

1,4-benzodiazepines

### Alternative Parents

Alpha amino acids and derivatives
/
Nitroaromatic compounds
/
Benzene and substituted derivatives
/
Secondary carboxylic acid amides
/
Lactams
/
Ketimines
/
Propargyl-type 1,3-dipolar organic compounds
/
Organic oxoazanium compounds
/
Azacyclic compounds
/
Organopnictogen compounds
/
Organic zwitterions
/
Organic oxides
/
Hydrocarbon derivatives
/
Carbonyl compounds
show 4 more

### Substituents

1,4-benzodiazepine
/
Allyl-type 1,3-dipolar organic compound
/
Alpha-amino acid or derivatives
/
Aromatic heteropolycyclic compound
/
Azacycle
/
Benzenoid
/
C-nitro compound
/
Carbonyl group
/
Carboxamide group
/
Carboxylic acid derivative
/
Hydrocarbon derivative
/
Imine
/
Ketimine
/
Lactam
/
Monocyclic benzene moiety
/
Nitroaromatic compound
/
Organic 1,3-dipolar compound
/
Organic nitro compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxoazanium
/
Organic oxygen compound
/
Organic zwitterion
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Propargyl-type 1,3-dipolar organic compound
/
Secondary carboxylic acid amide
show 18 more

### Molecular Framework

Aromatic heteropolycyclic compounds

### External Descriptors

C-nitro compound, 1,4-benzodiazepinone (
CHEBI:7581
)

### Affected organisms

Humans and other mammals

### UNII

9CLV70W7HS

### CAS number

146-22-5

### InChI Key

KJONHKAYOJNZEC-UHFFFAOYSA-N

### InChI

InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)

### General References

Rickels K: The clinical use of hypnotics: indications for use and the need for a variety of hypnotics. Acta Psychiatr Scand Suppl. 1986;332:132-41. [
Article
]
Robertson MD, Drummer OH: Postmortem drug metabolism by bacteria. J Forensic Sci. 1995 May;40(3):382-6. [
Article
]
Oelschlager H: [Chemical and pharmacologic aspects of benzodiazepines]. Schweiz Rundsch Med Prax. 1989 Jul 4;78(27-28):766-72. [
Article
]
Podhorna J, Krsiak M: Behavioural effects of a benzodiazepine receptor partial agonist, Ro 19-8022, in the social conflict test in mice. Behav Pharmacol. 2000 Apr;11(2):143-51. [
Article
]
Nowakowska E, Chodera A: Studies on the involvement of opioid mechanism in the locomotor effects of benzodiazepines in rats. Pharmacol Biochem Behav. 1991 Feb;38(2):265-6. [
Article
]

### External Links

Human Metabolome Database
HMDB0015534
KEGG Drug
D00531
KEGG Compound
C07487
PubChem Compound
4506
PubChem Substance
46505806
ChemSpider
4350
BindingDB
50020856
RxNav
7440
ChEBI
7581
ChEMBL
CHEMBL13209
ZINC
ZINC000004311748
Therapeutic Targets Database
DAP000691
PharmGKB
PA10242
Wikipedia
Nitrazepam

### Human Metabolome Database

HMDB0015534

### KEGG Drug

D00531

### KEGG Compound

C07487

### PubChem Compound

4506

### PubChem Substance

46505806

### ChemSpider

4350

### BindingDB

50020856

### RxNav

7440

### ChEBI

7581

### ChEMBL

CHEMBL13209

### ZINC

ZINC000004311748

### Therapeutic Targets Database

DAP000691

### PharmGKB

PA10242

### Wikipedia

Nitrazepam

### Dosage Forms

Form
Route
Strength
Tablet, film coated
Oral
5 MG
Tablet
Oral
10 mg/1
Tablet
Oral
Tablet
Oral
5 mg
Tablet
Oral
10 mg

### Prices

Unit description
Cost
Unit
Mogadon 10 mg Tablet
0.24USD
tablet
Mogadon 5 mg Tablet
0.16USD
tablet
Apo-Nitrazepam 10 mg Tablet
0.13USD
tablet
Nitrazadon 10 mg Tablet
0.11USD
tablet
Sandoz Nitrazepam 10 mg Tablet
0.11USD
tablet
Apo-Nitrazepam 5 mg Tablet
0.09USD
tablet
Nitrazadon 5 mg Tablet
0.08USD
tablet
Sandoz Nitrazepam 5 mg Tablet
0.08USD
tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.

### State

Solid

### Experimental Properties

Property
Value
Source
melting point (°C)
225 °C
PhysProp
logP
2.25
HANSCH,C ET AL. (1995)
logS
-3.8
ADME Research, USCD

### Predicted Properties

Property
Value
Source
Water Solubility
0.0299 mg/mL
ALOGPS
logP
1.95
ALOGPS
logP
2.55
Chemaxon
logS
-4
ALOGPS
pKa (Strongest Acidic)
11.66
Chemaxon
pKa (Strongest Basic)
2.65
Chemaxon
Physiological Charge
0
Chemaxon
Hydrogen Acceptor Count
4
Chemaxon
Hydrogen Donor Count
1
Chemaxon
Polar Surface Area
84.6 Å
2
Chemaxon
Rotatable Bond Count
2
Chemaxon
Refractivity
78.21 m
3
·mol
-1
Chemaxon
Polarizability
27.67 Å
3
Chemaxon
Number of Rings
3
Chemaxon
Bioavailability
1
Chemaxon
Rule of Five
Yes
Chemaxon
Ghose Filter
Yes
Chemaxon
Veber's Rule
No
Chemaxon
MDDR-like Rule
No
Chemaxon

### Predicted ADMET Features

Property
Value
Probability
Human Intestinal Absorption
+
0.9925
Blood Brain Barrier
+
0.9802
Caco-2 permeable
+
0.5176
P-glycoprotein substrate
Substrate
0.5785
P-glycoprotein inhibitor I
Non-inhibitor
0.8782
P-glycoprotein inhibitor II
Non-inhibitor
0.9205
Renal organic cation transporter
Non-inhibitor
0.8307
CYP450 2C9 substrate
Non-substrate
0.7695
CYP450 2D6 substrate
Non-substrate
0.8583
CYP450 3A4 substrate
Substrate
0.6725
CYP450 1A2 substrate
Inhibitor
0.7569
CYP450 2C9 inhibitor
Non-inhibitor
0.6133
CYP450 2D6 inhibitor
Non-inhibitor
0.8986
CYP450 2C19 inhibitor
Inhibitor
0.5682
CYP450 3A4 inhibitor
Inhibitor
0.6791
CYP450 inhibitory promiscuity
High CYP Inhibitory Promiscuity
0.5645
Ames test
Non AMES toxic
0.9132
Carcinogenicity
Non-carcinogens
0.7197
Biodegradation
Not ready biodegradable
1.0
Rat acute toxicity
2.5397 LD50, mol/kg
Not applicable
hERG inhibition (predictor I)
Weak inhibitor
0.9904
hERG inhibition (predictor II)
Non-inhibitor
0.8498
ADMET data is predicted using
admetSAR
, a free tool for evaluating chemical ADMET properties. (
23092397
)

### Spectra

Spectrum
Spectrum Type
Splash Key
Predicted GC-MS Spectrum - GC-MS
Predicted GC-MS
splash10-0il0-0190000000-e010be5805d1bd8c4980
Mass Spectrum (Electron Ionization)
MS
splash10-0zgi-2490000000-84b5bf7df62c745f8414
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-001i-0090000000-8f7713c4e618326c1d9b
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-0udi-0090000000-d514d232dff7c473d32f
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-0udi-0090000000-e2a1a64f13da7ed85586
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-0uk9-0190000000-f22bb948e3a20dfd2bff
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-006x-0980000000-f78bdd1a7e391dbaad48
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-014l-0920000000-d334a1a23130e08b3d55
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-014i-1900000000-3808670d5ccc91bd0e38
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-0uxu-3900000000-1fc08ceb9c88d5c734ca
LC-MS/MS Spectrum - LC-ESI-QFT , negative
LC-MS/MS
splash10-0udi-5900000000-cbcd46c7ea13a9ff18cb
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-00lr-0090000000-bc49e652f5e2e4f4b760
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-001i-0090000000-c63c1250878b61e6d0da
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-001i-0090000000-02d4e0b73c57e157d6b0
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-0019-0090000000-6623ad5dc09e01b5a573
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-000i-0390000000-38d5874ebcc0e05f411c
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-053r-0970000000-ce2d7caefc3860d70fa4
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-053r-0930000000-670ac85a651f0faf0d7d
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-0udi-1900000000-f96a507afa68e1b3a438
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-0udi-2900000000-c9082e2a3a5a56cfe408
LC-MS/MS Spectrum - LC-ESI-QFT , positive
LC-MS/MS
splash10-0udi-3900000000-310a824d6452fa47d987
MS/MS Spectrum - , positive
LC-MS/MS
splash10-001i-0190000000-6d4a0096179c1ef67c5a
1H NMR Spectrum
1D NMR
Not Applicable
13C NMR Spectrum
1D NMR
Not Applicable
Predicted 1H NMR Spectrum
1D NMR
Not Applicable
Predicted 13C NMR Spectrum
1D NMR
Not Applicable

### Chromatographic Properties

Collision Cross Sections (CCS)
Adduct
CCS Value (Å
2
)
Source type
Source
[M-H]-
176.0240718
predicted
DarkChem Lite v0.1.0
[M-H]-
176.1321718
predicted
DarkChem Lite v0.1.0
[M-H]-
158.75526
predicted
DeepCCS 1.0 (2019)
[M+H]+
176.5661718
predicted
DarkChem Lite v0.1.0
[M+H]+
176.3501718
predicted
DarkChem Lite v0.1.0
[M+H]+
161.11327
predicted
DeepCCS 1.0 (2019)
[M+Na]+
176.1739718
predicted
DarkChem Lite v0.1.0
[M+Na]+
175.8204718
predicted
DarkChem Lite v0.1.0
[M+Na]+
167.81229
predicted
DeepCCS 1.0 (2019)

### Kind

Protein

### Organism

Humans

### Pharmacological action

Unknown

### Actions

Inhibitor

### Curator comments

Benzodiazepines modulate GABA(A) function by binding at the interface between alpha (α) and gamma (γ) subunits. Of the 6 α-subunits, only 4 (α-1, -2, -3, and -5) participate in the formation of this binding site. The above target is a collection of all α- and γ-subunits that are known to participate in the formation of the benzodiazepine binding site.

### General Function

A cytochrome P450 monooxygenase involved in the metabolism of fatty acids (PubMed:10553002, PubMed:18577768). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:10553002, PubMed:18577768). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates fatty acids specifically at the omega-1 position displaying the highest catalytic activity for saturated fatty acids (PubMed:10553002, PubMed:18577768). May be involved in the oxidative metabolism of xenobiotics (Probable)

### Specific Function

4-nitrophenol 2-monooxygenase activity

### Gene Name

CYP2E1

### Uniprot ID

P05181

### Uniprot Name

Cytochrome P450 2E1

### Molecular Weight

56848.42 Da

